vVARDIS’ Drill-Free Solution Curodont™ Has Treated Over One Million Teeth in 18 Months.

Clinical adoption of Curodont™ is helping to elevate the standard of care in caries management leading clinical experts herald Curodont™ as a true step forward in the treatment of early decay.

vVARDIS Secures $50 Million in New Funding

Totalling $85 Million in Financing from Global Healthcare Investor OrbiMed – to Expand Rollout of Curodont™, Its Drill-Free Early Tooth Decay Treatment

Pearl Announces Global Collaboration with vVARDIS to Transform Early Detection and Proactive Treatment of Early Dental Decay

By leveraging AI, Pearl enables dental practitioners to detect tooth decay earlier while vVARDIS Curodont™ products offer a drill-free solution to treat early stages of tooth decay.

VideaHealth and vVARDIS Team Up, Elevating Preventative Dental Care for Millions

Power of improved diagnostic capabilities and early caries treatment will deliver measurably better insights and patient care.

vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment for Early Tooth Decay.

vVARDIS, a Swiss high growth dental company, and OrbiMed, a leading healthcare investment firm, today announced the closing of a $35 million financing. 

Henry Schein to Serve as Exclusive Distributor of Curodont to Dental Service Organizations

Henry Schein, Inc. (Nasdaq: HSIC) announced that it has reached an agreement with the Swiss company vVARDIS to serve as the exclusive distributor of their drill-free Curodont™ Repair Fluoride Plus product to larger dental service organizations (DSOs) in the U.S.